New Product Newswire for February 9, 2004
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
FDA Approves Cyclobenzaprine Sublingual Tablets for Treatment of Fibromyalgia
Episode 8: Stay in Sync with Innovations in Medication Decision Support
FDA Approves Fremanezumab as First Anti-CGRP Drug for Prevention of Pediatric Episodic Migraine
FDA Approves Biktarvy for Patients With HIV Previously Treated With Antiretroviral Therapy
FDA Approves Concizumab as Daily Prophylaxis for Hemophilia A and B
FDA Approves Finerenone for Heart Failure With Left Ventricular Ejection Fraction